Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elise Larouzee"'
Autor:
C. Sallée, T. de la Motte Rouge, A. Lacorre, Elise Larouzee, M. Koskas, E. Chereau, E. Gauroy, Tristan Gauthier, F. Margueritte
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie. 48:248-259
Resume Objectif Evaluer l’epidemiologie et les facteurs de risque de recidive et les modalites de surveillance en cas de tumeur frontiere de l’ovaire (TFO) ainsi que l’interet d’une chirurgie de cloture dans le cadre des recommandations pour
Autor:
A. Lacorre, M. Koskas, T. de la Motte Rouge, E. Chereau, Elise Larouzee, C. Sallée, E. Gauroy, Tristan Gauthier, F. Margueritte
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie. 48:314-321
Resume Objectif Editer des recommandations pour le diagnostic et la prise en charge des recidives de tumeurs frontieres de l’ovaire (TFO). Methode Revue de la litterature interrogeant les bases Medline, Pubmed et Cochrane. Resultats En cas de TFO,
Autor:
Sebastien Clement De Givry, Margot Bucau, Elise Larouzee, Nathalie Chabbert-Buffet, Samia Ouasti, Martin Koskas
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and ObstetricsREFERENCES. 157(2)
Objective Fertility-sparing treatment is based on progestin therapy and is known to be safe and effective. International recommendations advise the use of megestrol acetate or medroxyprogesterone acetate. However, chlormadinone acetate has fewer unde
Autor:
Joseph Gligorov, Sonia Zilberman, Elise Larouzee, Clémentine Owen, Anna Ilenko, Nathalie Chabbert-Buffet, Sofiane Bendifallah, Lise Selleret, Anne-Sophie Boudy, Lucie Allegre, Emile Daraï, Isabelle Thomassin-Naggara, Sandrine Richard
Publikováno v:
Journal of Gynecology Obstetrics and Human Reproduction
Journal of Gynecology Obstetrics and Human Reproduction, Elsevier, 2021, 50, pp.101766-. ⟨10.1016/j.jogoh.2020.101766⟩
Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50, pp.101766-. ⟨10.1016/j.jogoh.2020.101766⟩
Journal of Gynecology Obstetrics and Human Reproduction, Elsevier, 2021, 50, pp.101766-. ⟨10.1016/j.jogoh.2020.101766⟩
Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50, pp.101766-. ⟨10.1016/j.jogoh.2020.101766⟩
Objective Pregnancy associated breast cancer (PABC) are defined as breast cancer diagnosed during pregnancy and during the year following delivery. The prediction of poor prognosis events (PPE) such as recurrence is a major medical challenge of manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3561855c32a752d3e8652530c38e1c2
https://hal.archives-ouvertes.fr/hal-03493173
https://hal.archives-ouvertes.fr/hal-03493173
Autor:
Geoffroy Canlorbe, M. Koskas, Blandine Courbiere, Lucie Rolland, L. Ouldamer, Isabelle Thomassin-Naggara, Jean-Luc Brun, Christine Rousset-Jablonski, F. Margueritte, Tristan Gauthier, Mojgan Devouassoux-Shisheboran, R. Fauvet, E. Chereau, Emilie Raimond, Emile Daraï, Caroline Eymerit-Morin, T. de la Motte Rouge, Jean Levêque, C. Abdel Wahab, Sofiane Bendifallah, K. Nyangoh-Timoh, Michael Grynberg, E. Gauroy, J. Raad, Henri Azaïs, Pauline Chauvet, E. Mathieu D’argent, Cyrille Huchon, Elise Larouzee, M. Zilliox, Nicolas Bourdel, Pascal Rousset, Catherine Uzan, Lise Lecointre, R. Ramanah, Pierre-Adrien Bolze
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2021, 256, pp.492. ⟨10.1016/j.ejogrb.2020.11.045⟩
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2021, 256, pp.492. ⟨10.1016/j.ejogrb.2020.11.045⟩
It is recommended to classify Borderline Ovarian Tumors (BOTs) according to the WHO classification. Transvaginal and suprapubic ultrasonography are recommended for the analysis of an ovarian mass (Grade A). In case of an undetermined ovarian lesion o
Autor:
Geoffroy Canlorbe, M. Koskas, Blandine Courbiere, Mojgan Devouassoux-Shisheboran, F. Margueritte, Elise Larouzee, Pauline Chauvet, Henri Azaïs, Christine Rousset-Jablonski, Emilie Raimond, T. de la Motte Rouge, K. Nyangoh-Timoh, Cyrille Huchon, E. Mathieu D’argent, E. Gauroy, R. Fauvet, Michael Grynberg, Nicolas Bourdel, Jean-Luc Brun, E. Chereau, Emile Daraï, J. Raad, L. Ouldamer, M. Zilliox, R. Ramanah, Jean Levêque, Catherine Uzan, Pascal Rousset, Sofiane Bendifallah, Caroline Eymerit-Morin, Lucie Rolland, Isabelle Thomassin-Naggara, Tristan Gauthier, A.W. Cendos, Pierre-Adrien Bolze, Lise Lecointre
Publikováno v:
Gynecologie Obstetrique Fertilite et Senologie
Gynecologie Obstetrique Fertilite et Senologie, 2020, 48 (3), pp.223-235. ⟨10.1016/j.gofs.2020.01.022⟩
Gynecologie Obstetrique Fertilite et Senologie, 2020, 48 (3), pp.223-235. ⟨10.1016/j.gofs.2020.01.022⟩
International audience; This work was carried out under the aegis of the CNGOF (Collège national des gynécologues et obstétriciens français) and proposes guidelines based on the evidence available in the literature. The objective was to define th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60276359e50308299984405f24cbc548
https://hal.archives-ouvertes.fr/hal-03227885
https://hal.archives-ouvertes.fr/hal-03227885
Autor:
Geoffroy Canlorbe, Lucie Rolland, Isabelle Thomassin-Naggara, Tristan Gauthier, Mojgan Devouassoux-Shisheboran, Pierre-Adrien Bolze, Thibault De La Motte Rouge, Emile Daraï, Cendos Abdel Wahab, Christine Rousset-Jablonski, K. Nyangoh-Timoh, R. Ramanah, P. Rousset, J. Raad, Michael Grynberg, Lise Lecointre, Jean Levêque, Jean-Luc Brun, M. Zilliox, M. Koskas, Blandine Courbiere, Emmanuelle Mathieu d'Argent, Cyrille Huchon, Catherine Uzan, Henri Azaïs, Nicolas Bourdel, Elise Larouzee, F. Margueritte, Lobna Ouldamer, Raffaèle Fauvet, Pauline Chauvet, Elisabeth Chereau, Emilie Raimond, E. Gauroy, Caroline Eymerit-Morin, Sofiane Bendifallah
Publikováno v:
Journal of Gynecology Obstetrics and Human Reproduction
Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50 (1), pp.101965. ⟨10.1016/j.jogoh.2020.101965⟩
Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50 (1), pp.101965. ⟨10.1016/j.jogoh.2020.101965⟩
The incidence (rate per 100 000) of borderline ovarian tumors (BOTs) increases progressively with age, starting at 15-19 years and peaking at around 4.5 cases per 100 000 at an age of 55-59 years (LE3) with a median age of 46 years. The five year sur
Autor:
K. Nyangoh-Timoh, Michael Grynberg, Christine Rousset-Jablonski, Elise Larouzee, Emmanuelle D’argent Mathieu, Emilie Raimond, Cendos Abdel Wahab, J. Raad, E. Gauroy, Sofiane Bendifallah, M. Koskas, Raffaèle Fauvet, Blandine Courbiere, Caroline Eymerit-Morin, Lobna Ouldamer, Pierre-Adrien Bolze, Emile Daraï, Jean Lévêque, Cyrille Huchon, Geoffroy Canlorbe, F. Margueritte, Pascal Rousset, Pauline Chauvet, Nicolas Bourdel, M. Zilliox, Jean-Luc Brun, Catherine Uzan, R. Ramanah, Lucie Rolland, Isabelle Thomassin-Naggara, Tristan Gauthier, Thibault De La Motte Rouge, E. Chereau, Henri Azaïs, Lise Lecointre, Mojgan Devouassoux-Shisheboran
Publikováno v:
Journal of Gynecology Obstetrics and Human Reproduction
Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50 (1), pp.101966. ⟨10.1016/j.jogoh.2020.101966⟩
Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50 (1), pp.101966. ⟨10.1016/j.jogoh.2020.101966⟩
In the Early Stages (ES) of Borderline Ovarian Tumor (BOT), if surgery without risk of tumor rupture is possible, then laparoscopy with protected extraction is recommended over laparotomy (Grade C). In case of bilateral serous ES BOT treatment with a